Semma Therapeutics - Providence Business News

Home Tags Semma Therapeutics

Thorne Sparkman joined Slater in 2000 as executive director of what was then known as the Slater Center for Interactive Technologies. He focuses on the earliest stage of company creation, including working with university-based teams commercializing research. / PBN PHOTO/RUPERT WHITELEY

Support the founders

Business Services 02/14/2020

Thorne Sparkman | Slater Technology Fund managing director As a seed-stage investor, I spend countless hours discovering and courting entrepreneurs, because the founders of today’s...

VERTEX HAS entered into an agreement to purchase Semma Therapeutics for $950 million in cash.

Vertex to acquire Semma Therapeutics

Technology 09/03/2019

PROVIDENCE – Vertex Pharmaceuticals Inc. has entered into an agreement to acquire Semma Therapeutics for $950 million in cash, the companies announced Tuesday. Both companies...

SEMMA THERAPEUTICS, a Massachusetts biotechnology company with ties to Providence, successfully raised millions of dollars to advance its work in the field of cell therapy to treat individuals with diabetes. / COURTESY SEMMA PHARMACEUTICAL

Semma Therapeutics raises $114M in Series B funding round

Financial Services 12/19/2017

PROVIDENCE – Semma Therapeutics, a Massachusetts biotechnology company with ties to Providence, recently raised $114 million in an equity financing round. The company, based in...

Briannan Bintz, 36 Director of encapsulation research — Semma Therapeutics

Health Services 07/20/2017

Where do you see yourself professionally in 20 years? I don’t think I would change much. I’d still like to be working on cutting-edge research...

- Featured Event -

Latest News

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.